ELOVL2 and glioblastoma: For instance, ELOVL2 was identified as an unique tissue-independent age-associated DNA methylation marker (42) and a specific superenhancer-associated gene implicated the LC-PUFA synthesis network as a critical metabolic dependency (43), and was associated with worsened patient survival in glioblastoma (44).